Data / Form D filings / Cara Therapeutics, Inc.
Cara Therapeutics, Inc.: Form D filings
Cara Therapeutics, Inc., a biotechnology company in Shelton, CT, filed 2 Form D notices with the SEC between 2010 and 2014. The latest, on December 11, 2014, reports $100,003 sold of a $100,003 offering to 1 investor.
Find out what Cara Therapeutics, Inc. does, who founded it and who invested, beyond what the filing says. $10 of credit on sign-up, no card.
SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.
Company details from the filing
- Address
- ONE PARROTT DRIVE, Shelton, CT, 06484
- Phone
- (203) 567-1500
- Industry
- Biotechnology
- Entity type
- Corporation
- Incorporated in
- Delaware
- Revenue range
- $5,000,001 - $25,000,000
- Exemptions claimed
- Rule 506(b)
- SEC identifier (CIK)
- 1346830
The full lists. Form D filings in Connecticut: 428 rows, $21.40, or the new rows each week for $19 a month. Form D filings in Biotechnology: 1,568 rows, $78.40, or the new rows each week for $19 a month. Pay by card with no account. Prices exclude VAT. CSV and Excel files with the columns this page does not show (company, CIK, year incorporated, street, city, state and 5 more), which open on your screen as soon as the payment clears and come by email. For agents and scripts: every list with its row count and price is at https://specstream.ai/data/lists.json.
Form D filings
| Filed | Type | Offering | Sold | Remaining | Investors | First sale | Filing |
|---|---|---|---|---|---|---|---|
| Dec 11, 2014 | New notice | $100,003 | $100,003 | $0 | 1 | Dec 1, 2014 | sec.gov |
| Jul 21, 2010 | New notice | $15,000,000 | $4,784,568 | $10,215,432 | 12 | Jul 19, 2010 | sec.gov |
Executive officers and directors named in the filing
| Name | Role | Note in the filing |
|---|---|---|
| Josef Schoell | Executive Officer | |
| Jeffrey L. Ives | Director | |
| Joseph W. Stauffer | Executive Officer | |
| Derek Chalmers | Executive Officer, Director | |
| Michael E. Lewis | Executive Officer | |
| Martin Vogelbaum | Director | |
| Dean Slagel | Director | |
| Frederique Menzaghi | Executive Officer | |
| Harrison Bains | Director |
Other biotechnology companies in Connecticut that filed recently
- Allyx Therapeutics, Inc. $27.9 million · Oct 21, 2026
- Cloverleaf Bio, Inc. $14.8 million · Sep 9, 2026
Every Form D from the week of Dec 8, 2014 · All recent filings in Connecticut · All recent Biotechnology filings
Read from SEC EDGAR. Amount sold is what Cara Therapeutics, Inc. reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.
$10 of credit on sign-up, no card.